LASA.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:58):

Stats
Šios dienos apimtis	43 298.00
Vidutinė apimtis	103 681
Rinkos kapitalizacija	1.28B
EPS	INR0 ( 2024-02-12 )
Kita pelno data	( INR0 ) 2024-06-05
Last Dividend	INR0.250 ( 2022-09-16 )
Next Dividend	INR0 ( N/A )
P/E	-8.01
ATR14	INR0.0370 (0.14%)

Tūris Koreliacija

Ilgas: -0.06 (neutral)

Trumpas: -0.45 (neutral)

Signal:(45.423) Neutral

Lasa Supergenerics Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Lasa Supergenerics Koreliacija - Valiuta/Žaliavos

-0.16
( neutral )

0.04
( neutral )

0.00
( neutral )

-0.27
( neutral )

0.08
( neutral )

0.23
( neutral )

Lasa Supergenerics Finansinės ataskaitos

Annual	2022
Pajamos:	INR1.30B
Bruto pelnas:	INR234.54M (18.10 %)
EPS:	INR-7.71

FY	2022
Pajamos:	INR1.30B
Bruto pelnas:	INR234.54M (18.10 %)
EPS:	INR-7.71

FY	2022
Pajamos:	INR1.37B
Bruto pelnas:	INR451.11M (32.90 %)
EPS:	INR-1.320

FY	2021
Pajamos:	INR2.02B
Bruto pelnas:	INR900.28M (44.48 %)
EPS:	INR5.60

Financial Reports:

No articles found.

Lasa Supergenerics Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.250 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Lasa Supergenerics Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.659 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.250	2021-09-15
Last Dividend	INR0.250	2022-09-16
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR0.500	--
Avg. Dividend % Per Year	0.10%	--
Score	0.78	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.659
Div. Directional Score	0.737	--

Next Divdend (Est)
(2024-07-01)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.78

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2021	INR0.250	0.30%
2022	INR0.250	0.36%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TIDEWATER.NS	Dividend Knight	2023-07-04	Semi-Annually	18	2.24%
PAISALO.NS	Dividend Junior	2023-09-14	Annually	16	0.10%
ITDC.NS	Dividend Junior	2023-09-20	Sporadic	8	0.17%
DAAWAT.NS	Dividend Junior	2023-09-21	Annually	18	1.02%
SHREYANIND.NS	Dividend Junior	2023-08-03	Annually	12	1.43%
MASFIN.NS	Dividend Junior	2023-07-19	Annually	8	0.28%
GRPLTD.NS	Dividend Junior	2023-07-28	Annually	10	0.46%
BANARISUG.NS	Dividend Junior	2023-08-28	Annually	22	0.34%
POWERINDIA.NS	Dividend Junior	2023-08-10	Annually	4	0.07%
JUBLINGREA.NS	Dividend Junior	2023-08-10	Semi-Annually	4	0.47%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.184	1.500	-3.67	-5.51	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.185	1.500	-3.17	-4.75	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-0.380	1.000	-1.252	-1.252	[3 - 30]
operatingCashFlowPerShareTTM	4.86	2.00	8.38	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.86	2.00	7.57	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.261	1.000	8.98	8.98	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00582	1.000	-2.12	-2.12	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.185

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.97	1.000	-0.704	0	[1 - 100]
returnOnEquityTTM	-0.185	2.50	-2.04	-4.75	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.86	2.00	8.38	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.86	2.00	8.38	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00962	1.500	-3.27	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.209	1.000	7.29	0	[0.1 - 0.5]
Total Score				1.659

Lasa Supergenerics

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.